SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is actively discussed following its recent European Commission approval for the oncology drug ANKTIVA and a new distribution partnership spanning 33 countries. The community is buzzing with strong bullish sentiment, anticipating a significant short squeeze driven by these global expansion catalysts and substantial short interest.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

The FDA's unexpected reversal to review Moderna's seasonal flu vaccine application, after an initial refusal, is propelling the stock higher, leading to widespread community discussion of a significant short squeeze and optimism for its broader mRNA pipeline.

Klarna Group Plc is a global digital bank and flexible payments provider. It operates through an AI-powered payments and commerce network that empowers people to pay smarter, with a mission to be available everywhere, for everything. The company was founded by Gustav Erik Niklas Adalberth, Karl Anders Victor Jacobsson, and Sebastian Marcin Siemiatkowski in 2005 and is headquartered in London, the United Kingdom.

Klarna Group plc

Klarna is trending after reporting a net loss despite strong revenue and gross merchandise volume growth, primarily driven by increased loan loss provisions, sparking community debate over the sustainability of its Buy Now, Pay Later model and its current valuation.

Walmart, Inc. engages in the retail and wholesale business. The company offers an assortment of merchandise and services at everyday low prices. It operates through the following business segments: Walmart U.S., Walmart International, and Sam's Club. The Walmart U.S. segment operates as a mass merchandiser of consumer products, operating under the Walmart and Walmart Neighborhood Market brands, including walmart.com. The Walmart International segment includes operations of wholly-owned subsidiaries in Canada, Chile, China, and Africa, and majority-owned subsidiaries in India, as well as Mexico and Central America. The Sam's Club segment manages membership-only warehouse clubs and operates samsclub.com. The company was founded by Samuel Moore Walton and James Lawrence Walton on July 2, 1962 and is headquartered in Bentonville, AR.

Walmart Inc

Walmart is a hot topic after its Q4 earnings, which, despite beating estimates, presented conservative forward guidance, sparking debate on its high valuation and a significant new $30 billion share buyback program amidst strong e-commerce and AI growth.

Starfighters Space, Inc. is engaged in the research and development of space flight, pilot training, and aeronautics programs. It operates the commercial fleet Lockhead F-104s. The company was founded by Rick Svetkoff on September 6, 2022 and is headquartered in Cape Canaveral, FL.

Starfighters Space Inc

Starfighters Space (FJET) is trending on the heels of its upcoming NYSE Opening Bell ceremony, sparking intense community speculation around a potential short squeeze due to its tight float, with many anticipating significant gains as the space sector heats up ahead of the highly anticipated Space X IPO.

Deere & Co. engages in the manufacture and distribution of equipment used in agriculture, construction, forestry, and turf care. It operates through the following segments: Agriculture and Turf, Construction and Forestry, and Financial Services. The Agriculture and Turf segment focuses on the distribution and manufacture of a full line of agriculture and turf equipment and related service parts. The Construction and Forestry segment offers machines and service parts used in construction, earthmoving, road building, material handling and timber harvesting. The Financial Services segment finances sales and leases by John Deere dealers of new and used agriculture and turf equipment and construction and forestry equipment. The company was founded by John Deere in 1837 and is headquartered in Moline, IL.

Deere & Co.

Deere & Co

Deere & Co is surging after exceeding earnings expectations and boosting its full-year outlook, with management signaling a bottom in the agricultural cycle driven by strong construction and small agriculture segments. While bulls celebrate the "monster run" and anticipate further analyst upgrades, a divided community expresses strong skepticism, citing "overvalued" fundamentals and "pure pump" action amid concerns over declining revenue and farmer spending.

One Stop Systems, Inc. engages in the design, manufacture, and marketing of computing modules and systems targeting edge deployments. It deals with the design and manufacture of high-performance customized computer and flash arrays, in-flight entertainment, and connectivity and value-added reseller with minimal customization. It operates through the OSS and OSS Europe segments. The company was founded by Stephen D. Cooper and Mark Gunn in 1998 and is headquartered in Escondido, CA.

One Stop Systems Inc

One Stop Systems (OSS) is trending sharply higher after securing $10.5 million in new U.S. Navy and defense contracts for its rugged Edge AI computing solutions. The community is highly bullish, citing undervaluation, a tight stock float, and anticipation of even larger defense and commercial robotics deals, believing the company is poised for significant growth in the Edge AI sector.

Medical Properties Trust, Inc. is a self-advised real estate investment trust. It engages in the investment, acquisition, and development of net-leased healthcare facilities. Its property portfolio includes rehabilitation hospitals, long-term acute care hospitals, ambulatory surgery centers, hospitals for women and children, regional and community hospitals, medical office buildings, and other single-discipline facilities. The company was founded by Edward K. Aldag Jr., R. Steven Hamner, Emmett E. McLean, and William Gilliard McKenzie in 2003 and is headquartered in Birmingham, AL.

Medical Properties Trust Inc

Medical Properties Trust (MPT) is trending as its recent earnings report and strategic actions have energized a community bullish on its turnaround story, with aggressive call buying and high short interest fueling intense discussions about a potential short squeeze.

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Lumentum is seeing intense discussion driven by its surging optical business, buoyed by robust demand from AI data center infrastructure that has led to substantial analyst upgrades. This rapid rise has created a polarized community, with many celebrating its "beast" like momentum while skeptics highlight extreme overvaluation relative to sales and significant insider selling, cautioning against a potential "mean reversion."

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending due to investor anticipation of the imminent BLA resubmission for its Duchenne muscular dystrophy therapy, Deramiocel, with strong Phase 3 data. The community is actively discussing increasing institutional interest and potential for significant upside as the company progresses with regulatory approvals and advances its exosome-based StealthX platform.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Prospector Partners LLC Makes New $4.18 Million Investment in Option Care Health, Inc. $OPCH

Prospector Partners LLC acquired a new stake in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) during the third quarter, according to the company in its most recent filing with the...

Option Care Health (OPCH) Projected to Post Earnings on Tuesday

Option Care Health (NASDAQ:OPCH) will be releasing its Q4 2025 earnings before the market opens on Tuesday, February 24. (View Earnings Report at...

Illinois Municipal Retirement Fund Raises Holdings in Option Care Health, Inc. $OPCH

Illinois Municipal Retirement Fund lifted its position in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 48.5% during the third quarter, according to its most recent Form 13F...

Quest Diagnostics (DGX) Beats Q4 Earnings and Revenue Estimates

Quest Diagnostics (DGX) delivered earnings and revenue surprises of +2.85% and +2.08%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Profit Therapy: 3 Medical Stocks Ready to Deliver Q4 Beat

THC, UHS and OPCH look poised to beat Q4 estimates as volumes, admissions and revenue trends improve.

Will Declining Medical Customers Affect Cigna's Q4 Earnings?

CI heads into Q4 earnings with rising Evernorth revenues but falling premiums and medical customers, raising questions about the quarter's overall growth outlook.

Can Operational Execution Support DaVita's Q4 Performance?

DVA's fourth-quarter 2025 performance is likely to have gained from technology upgrades, cost control and seasonal boosts despite ongoing volume headwinds.

Why Option Care (OPCH) Could Beat Earnings Estimates Again

Option Care (OPCH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Massachusetts Financial Services Co. MA Buys 33,019 Shares of Option Care Health, Inc. $OPCH

Massachusetts Financial Services Co. MA boosted its position in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 2.7% during the 3rd quarter, according to the company in its most...

Option Care Health (NASDAQ:OPCH) Hits New 52-Week High - Should You Buy?

Option Care Health (NASDAQ:OPCH) Hits New 52-Week High - Here's Why...

Option Care Health, Inc. engages in the provision of home and alternate site infusion services. The firm provides infusion therapy and other ancillary healthcare services through a national network of full-service pharmacies. The company contracts with managed care organizations, third-party payers, hospitals, physicians, and other referral sources to provide pharmaceuticals and complex compounded solutions to patients for intravenous delivery in the patients’ homes or other nonhospital settings. Its home infusion services consist of anti-infectives, nutrition support, bleeding disorder therapies, immunoglobulin therapy, and other therapies for chronic and acute conditions. The company was founded in 1996 and is headquartered in Bannockburn, IL.

Current Price	$35.43
Prev Close	$35.50
Open	$35.20
Dividend Yield	0.00%
50-Day Moving Average	$33.62
Beta	0.63
Avg. Volume	1.94M
PE Ratio	28.19

52-Week High	$36.80
52-Week Low	$24.24
Market Capitalization	$5.65B
EPS (Annual)	$1.23
Price to Book	4.18
Revenue Per Employee	$830,956.28

OPCH
Option Care Health Inc. - Registered Shares

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest OPCH News

OPCHOption Care Health Inc. - Registered Shares